{"schema_version":"1","generated_at":"2026-11-05T06:51:23.281Z","data_as_of":null,"url":"https://www.findmykol.com/kol/george-hucks","json_url":"https://www.findmykol.com/kol/george-hucks/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"george-hucks","name":"George Hucks","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of North Carolina at Chapel Hill","institution_url":"https://www.findmykol.com/institution/university-of-north-carolina-at-chapel-hill","city":"Greenville","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1265611289","orcid":"0000-0002-4515-7277","openalex":"A5035811418"},"summary":"George Hucks is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 17 publications with 528 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":17,"cited_by_count":528,"h_index":9,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03721068","title":"Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"UNC Lineberger Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT03721068","trial_url":"https://www.findmykol.com/trial/NCT03721068"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Incyte Corporation","program_year":2025,"amount_usd":23.19,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265611289"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1265611289","source":"payments"},"publications":{"total":17,"shown":5,"withheld":12,"matched_by":"OpenAlex author record","recent":[{"title":"141 | CD30 CAR‐T IN RELAPSED AND REFRACTORY CD30+ LYMPHOMAS: LONG‐TERM FOLLOW‐UP OF A PHASE IB/II CLINICAL TRIAL","year":2025,"journal":"Hematological Oncology","source_url":"https://doi.org/10.1002/hon.70093_141","status":"verified"},{"title":"Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study","year":2024,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(24)00064-4","status":"verified"},{"title":"Safety and Efficacy of CD30.CAR-T Cells as Consolidation Post Autologous Transplant in High-Risk CD30 Lymphoma","year":2024,"journal":"SSRN Electronic Journal","source_url":"https://doi.org/10.2139/ssrn.4689900","status":"verified"},{"title":"Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX‐351 and inotuzumab","year":2023,"journal":"Pediatric Blood & Cancer","source_url":"https://doi.org/10.1002/pbc.30645","status":"verified"},{"title":"Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma","year":2022,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2022-156660","status":"verified"}],"source":"works"},"contact":{"address_1":"600 MOYE BLVD","address_2":"ECU PHYSICIANS HEM/ONC MODULE F","city":"Greenville","state":"NC","zip":"278344300","phone":"252-744-2335","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1265611289","source":"identity"},"similar":[{"name":"Diana Perkins","slug":"diana-perkins","institution":"University of North Carolina at Chapel Hill","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/diana-perkins","json_url":"https://www.findmykol.com/kol/diana-perkins/profile.json"},{"name":"Douglas Drossman","slug":"douglas-drossman","institution":"University of North Carolina at Chapel Hill","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/douglas-drossman","json_url":"https://www.findmykol.com/kol/douglas-drossman/profile.json"},{"name":"Michael Knowles","slug":"michael-knowles","institution":"University of North Carolina at Chapel Hill","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/michael-knowles","json_url":"https://www.findmykol.com/kol/michael-knowles/profile.json"},{"name":"David Margolis","slug":"david-margolis","institution":"University of North Carolina at Chapel Hill","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/david-margolis","json_url":"https://www.findmykol.com/kol/david-margolis/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":12}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-01-07","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}